| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1029515640 |
| P356 | DOI | 10.1038/SJ.BMT.1703855 |
| P698 | PubMed publication ID | 12634731 |
| P5875 | ResearchGate publication ID | 10857872 |
| P50 | author | Marcio Nucci | Q37837344 |
| P2093 | author name string | Pulcheri W | |
| Lima J | |||
| Maiolino A | |||
| Biasoli I | |||
| Portugal AC | |||
| P2860 | cites work | Increased frequency of autoaggression syndrome associated with autologous stem cell transplantation in breast cancer patients | Q33499065 |
| 2002 guidelines for the use of antimicrobial agents in neutropenic patients with cancer | Q34114674 | ||
| Engraftment syndrome following hematopoietic stem cell transplantation | Q34298239 | ||
| A randomized, multicenter study of G-CSF starting on day +1 vs day +5 after autologous peripheral blood progenitor cell transplantation. | Q40581439 | ||
| Application of the IDSA guidelines for the use of antimicrobial agents in neutropenic patients: impact on reducing the use of glycopeptides | Q40590894 | ||
| An engraftment syndrome in autologous stem cell transplantation related to mononuclear cell dose | Q40624714 | ||
| Nosocomial Outbreak ofExophiala jeanselmeiFungemia Associated with Contamination of Hospital Water | Q56970574 | ||
| A Double-Blind, Randomized, Placebo-Controlled Trial of Itraconazole Capsules as Antifungal Prophylaxis for Neutropenic Patients | Q56970601 | ||
| From the Immunocompromised Host Society. The design, analysis, and reporting of clinical trials on the empirical antibiotic management of the neutropenic patient. Report of a consensus panel | Q68497120 | ||
| P433 | issue | 5 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 393-397 | |
| P577 | publication date | 2003-03-01 | |
| P1433 | published in | Bone Marrow Transplantation | Q4941523 |
| P1476 | title | Engraftment syndrome following autologous hematopoietic stem cell transplantation: definition of diagnostic criteria | |
| P478 | volume | 31 |
| Q44971633 | A rare case of interstitial pneumonitis after tandem high-dose melphalan conditioning and autologous stem cell transplantation in multiple myeloma |
| Q40306199 | Acute kidney injury during leukocyte engraftment after autologous stem cell transplantation in patients with light-chain amyloidosis |
| Q92600857 | Allogeneic reactivity-mediated endothelial cell complications after HSCT: a plea for consensual definitions |
| Q39006094 | Association between C-reactive protein levels in the first 1-3 days post-transplant and allogeneic immune reactions |
| Q43920667 | At-home autologous stem cell transplantation in multiple myeloma with and without G-CSF administration: a comparative study |
| Q40536686 | Clinical impact of hyperacute graft-versus-host disease on results of allogeneic stem cell transplantation |
| Q84007987 | Colitis secondary to engraftment syndrome in a patient with autologous peripheral blood stem cell transplant |
| Q36847555 | Combination antifungal therapy: what can and should we expect? |
| Q54253594 | Current Approach to Non-Infectious Pulmonary Complications of Hematopoietic Stem Cell Transplantation. |
| Q95567275 | Early and Acute Complications and the Principles of HSCT Nursing Care |
| Q36264701 | Engraftment Syndrome after Autologous Stem Cell Transplantation: An Update Unifying the Definition and Management Approach |
| Q96306763 | Engraftment Syndrome and Acute Graft-versus-Host Disease: A Meta-Analysis |
| Q39222708 | Engraftment syndrome after allogeneic hematopoietic cell transplantation in adults |
| Q34079430 | Engraftment syndrome after allogeneic hematopoietic cell transplantation predicts poor outcomes. |
| Q43198285 | Engraftment syndrome after auto-SCT: analysis of diagnostic criteria and risk factors in a large series from a single center |
| Q40522096 | Engraftment syndrome after autologous peripheral blood progenitor cell transplantation in pediatric patients: a prospective evaluation of risk factors and outcome. |
| Q79206227 | Engraftment syndrome after hematopoietic stem cell transplantation in multiple myeloma |
| Q38315390 | Engraftment syndrome: double-edged sword of hematopoietic cell transplants |
| Q40452463 | Epidemiology of bacteremia and factors associated with multi-drug-resistant gram-negative bacteremia in hematopoietic stem cell transplant recipients. |
| Q40108868 | Evaluation of engraftment syndrome in children following full-matched related donor hematopoietic stem cell transplantations |
| Q36328397 | Evaluation of pulmonary infiltrates in patients after stem cell transplantation |
| Q40119879 | Favorable outcome to glucocorticoid therapy for engraftment syndrome in pediatric autologous hematopoietic cell transplant |
| Q44897853 | Gastrointestinal pathology of autologous graft-versus-host disease following hematopoietic stem cell transplantation: a clinicopathological study of 17 cases |
| Q40148308 | High incidence of engraftment syndrome after haploidentical allogeneic stem cell transplantation. |
| Q39152763 | Higher dose of CD34+ peripheral blood stem cells is associated with better survival after haploidentical stem cell transplantation in pediatric patients |
| Q49716209 | How I treat acute graft versus host disease |
| Q47172970 | Impact of Oral and Gastrointestinal Mucositis on Body Weight Alterations during Hematopoietic Stem Cell Transplantation |
| Q91142736 | Improving security of autologous hematopoietic stem cell transplant in patients with light-chain amyloidosis |
| Q30276715 | Incidence, etiology, and outcome of pleural effusions in allogeneic hematopoietic stem cell transplantation. |
| Q38096877 | Inflammatory markers in patients after hematopoietic stem cell transplantation |
| Q40140952 | Infusion-related febrile reaction after haploidentical stem cell transplantation in children is associated with higher rates of engraftment syndrome and acute graft-versus-host disease. |
| Q88506851 | Innovative strategies minimize engraftment syndrome in multiple myeloma patients with novel induction therapy following autologous hematopoietic stem cell transplantation |
| Q90357548 | Late-onset fever and engraftment syndrome following autologous stem cell transplant: Impact on resource utilization |
| Q36406434 | Macrophage activation syndrome and other systemic inflammatory conditions after BMT. |
| Q47714833 | Noninfectious Acute Lung Injury Syndromes Early After Hematopoietic Stem Cell Transplantation |
| Q40273597 | Peri-engraftment syndrome in allogeneic hematopoietic SCT. |
| Q36575315 | Peripheral blood stem cell transplant for POEMS syndrome is associated with high rates of engraftment syndrome |
| Q83885727 | Post-autologous hematopoietic SCT engraftment syndrome: a single center experience |
| Q34985679 | Pre-engraftment syndrome after double-unit cord blood transplantation: a distinct syndrome not associated with acute graft-versus-host disease |
| Q36983064 | Pre-engraftment syndrome after myeloablative dual umbilical cord blood transplantation: risk factors and response to treatment |
| Q36854422 | Pre-engraftment syndrome in hematopoietic stem cell transplantation |
| Q104064700 | Prior anti-PD-1 therapy as a risk factor for life-threatening peri-engraftment respiratory distress syndrome in patients undergoing autologous stem cell transplantation |
| Q90484595 | Procalcitonin as a biomarker to differentiate bacterial infections from engraftment syndrome following autologous hematopoietic stem cell transplantation for multiple myeloma |
| Q99730640 | Prophylactic corticosteroid use prevents engraftment syndrome in patients after autologous stem cell transplantation |
| Q38215237 | Pulmonary complications of childhood cancers |
| Q35740698 | Pulmonary complications of solid organ and hematopoietic stem cell transplantation |
| Q33944909 | Pulmonary manifestations of the pre-engraftment syndrome after umbilical cord blood transplantation |
| Q40386808 | Safety and efficacy of allogeneic hematopoietic stem cell transplant after PD-1 blockade in relapsed/refractory lymphoma. |
| Q40517545 | Steroids prevent engraftment syndrome after autologous hematopoietic stem cell transplantation without increasing the risk of infection |
| Q40347834 | Syngeneic Donor Hematopoietic Stem Cell Transplantation Is Associated with High Rates of Engraftment Syndrome |
| Q94671653 | The induction strategies administered in the treatment of multiple myeloma exhibit a deleterious effect on the endothelium |
| Q37796528 | The spectrum of noninfectious pulmonary complications following hematopoietic stem cell transplantation |
| Q48458866 | The yield and safety of thoracentesis in hematopoietic stem cell transplantation recipients |
Search more.